CMS Proposes Coverage For Colorectal Cancer Blood-Based Tests – Except For Epigenomics’ Screen

 
• By Sue Darcey

The US Medicare agency coupled its proposed coverage memo on colorectal cancer screens based on blood-based biomarker tests with a note that the Epi proColon assay does not meet its criteria.

Medicare has issued a proposed decision memo for screening for colorectal cancer

More from Policy & Regulation

More from Medtech Insight